RONALD MCGAVIC: Open Payments
NPI 1649683640 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$766 in 34 payments from 12 companies in 2025. Trend: 2023 $2,636 · 2024 $914 · 2025 $766
Food & beverage: $766
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $190 |
| Otsuka America Pharmaceutical, Inc. | 2 | $123 |
| Bausch Health US, LLC | 6 | $122 |
| Tris Pharma Inc | 4 | $75 |
| Lundbeck LLC | 3 | $66 |
| Vanda Pharmaceuticals Inc. | 3 | $63 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $27 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $17 |
Products named: VRAYLAR, REXULTI, APLENZIN, Dyanavel XR, HETLIOZ, Auvelity, CAPLYTA, WELLBUTRIN.
Industry payments across KY — which companies pay providers there.
